Oxford Nanopore
Oxford Nanopore Technologies was founded in 2005 to develop an electronic, single molecule sensing system based on nanopore science. The company now has more than 250 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialization. Oxford Nanopore's instruments â MinIon, PromethIon, and GridIon are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule.
Oxford Nanopore Facts
CEO: Gordon Sanghera
Website: www.nanoporetech.com
Ticker symbol: Privately held
Headquarters: Oxford, UK
Number of employees: 250+
Singapore’s Precision Medicine Program to Analyze 10K Genomes With Nanopore Sequencing
The project will use Oxford Nanopore Technologies’ PromethIon 48 device to sequence 10,000 genomes representing Singapore’s diverse populations.
Oxford Nanopore Technologies, Twist Bioscience Partner for Pharmacogenomics Beta Program
The program aims to integrate Twist’s NGS target enrichment technology with Oxford Nanopore’s sequencing platform to develop long-read PGx workflows.